Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer

Eatock, M.M., Tebbutt, N.C., Bampton, C.L. · Annals of Oncology · 2013